• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Number of waivers granted per month to advisory committee members participating in meetings

Dictionary: When FDA determines that an advisory committee member has a financial conflict of interest, the agency may grant a waiver that allows the member to participate in an advisory committee meeting if certain criteria and policies are met. In general, FDA may grant a waiver if the requirements set forth by 18 U.S.C. 208 are met. FDA searches for experts who have the necessary expertise without conflicts of interest; yet, in some cases, the top authorities in specialized scientific fields may have a conflict of interest. When FDA grants a waiver, the financial interests associated with the waiver are posted on FDA’s website along with the reasons for granting the waiver.

Information is current as of September 30, 2021.

Fiscal Year - 2021

Skip graphic and jump to text data

TimeTargetWaivers Granted
Oct 2020N/A2
Nov 2020N/A0
Dec 2020N/A2
Jan 2021N/A0
Feb 2021N/A4
Mar 2021N/A0
Apr 2021N/A6
May 2021N/A1
Jun 2021N/A2
Jul 2021N/A1
Aug 2021N/A0
Sep 2021N/A0

FY 2021 Total: 18

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.